Gödde-Salz E, Feller A C, Lennert K
Leuk Res. 1986;10(3):313-23. doi: 10.1016/0145-2126(86)90028-7.
In 1968 a special variant of Hodgkin's disease, epithelioid cellular lymphogranulomatosis--later on termed lymphoepithelioid cell lymphoma/Lennert's lymphoma--was defined. There are increasing indicators that Lennert's lymphoma is of T-cell origin. Seven cases of Lennert's lymphoma are studied with cytogenetic as well as immunohistochemical techniques. Six of them have cytogenetic abnormal clones always including aberrations of chromosome No. 3 (+3, break in q22, dup q22----q24). In all cases band 3q22 is either broken or duplicated. Immunohistochemically it is clearly demonstrated that the proliferating cells are of T-cell nature (Ki67+, Leu4+, Leu1+). Under consideration in the literature it can be stated in conclusion that (1) lymphoepithelioid cell lymphoma (Lennert's lymphoma) with aberrations has to be designated as malignant lymphoma, (2) immunohistochemical double labeling proved the T-cell nature of this lymphoma, (3) there are remarkable similarities between the chromosomal patterns of lymphoepithelioid cell lymphoma, lymphogranulomatosis X/angioimmunoblastic lymphadenopathy and probably Hodgkin's disease: many normal mitoses and abnormalities of chromosome No. 3, especially trisomy. It is discussed that abnormalities of chromosome No. 3 involving band q22 are an indicator of a common genetic background of these lymphomas.
1968年,霍奇金病的一种特殊变体——上皮样细胞性淋巴肉芽肿病(后来被称为淋巴上皮样细胞淋巴瘤/ Lennert淋巴瘤)被定义。越来越多的指标表明Lennert淋巴瘤起源于T细胞。应用细胞遗传学和免疫组化技术对7例Lennert淋巴瘤进行了研究。其中6例有细胞遗传学异常克隆,总是包括3号染色体的畸变(+3、q22断裂、q22→q24重复)。在所有病例中,3q22带要么断裂要么重复。免疫组化清楚地表明增殖细胞具有T细胞性质(Ki67+、Leu4+、Leu1+)。综合文献考虑,可以得出以下结论:(1)伴有畸变的淋巴上皮样细胞淋巴瘤(Lennert淋巴瘤)必须被认定为恶性淋巴瘤;(2)免疫组化双重标记证明了这种淋巴瘤的T细胞性质;(3)淋巴上皮样细胞淋巴瘤、X线淋巴肉芽肿病/血管免疫母细胞性淋巴结病以及可能的霍奇金病的染色体模式之间存在显著相似性:许多正常有丝分裂和3号染色体异常,尤其是三体性。有人讨论说,涉及q22带的3号染色体异常是这些淋巴瘤共同遗传背景的一个指标。